Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medicine and Health Sciences (7840)
- Medical Sciences (7802)
- Medical Specialties (7049)
- Diseases (1830)
- Life Sciences (1552)
-
- Pediatrics (1344)
- Public Health (1154)
- Medical Molecular Biology (1097)
- Biological Phenomena, Cell Phenomena, and Immunity (992)
- Medical Genetics (946)
- Biomedical Informatics (688)
- Oncology (599)
- Neurosciences (557)
- Mental and Social Health (548)
- Biochemistry, Biophysics, and Structural Biology (543)
- Health Services Research (535)
- Neurology (499)
- Cardiology (478)
- Medical Cell Biology (409)
- Genetics and Genomics (408)
- Gastroenterology (402)
- Surgery (391)
- Digestive System Diseases (380)
- Biology (357)
- Endocrinology, Diabetes, and Metabolism (355)
- Cardiovascular Diseases (308)
- Genetic Phenomena (304)
- Epidemiology (289)
- Microbiology (287)
- Medical Microbiology (281)
- Keyword
-
- Humans (4499)
- Female (1938)
- Male (1727)
- Animals (1524)
- Mice (1038)
-
- Adult (816)
- Child (810)
- Middle Aged (741)
- Aged (594)
- Adolescent (490)
- Retrospective Studies (433)
- Infant (403)
- United States (387)
- Preschool (368)
- Child, Preschool (365)
- Risk Factors (321)
- COVID-19 (304)
- Treatment Outcome (284)
- Young Adult (268)
- Inbred C57BL (240)
- Mice, Inbred C57BL (240)
- Biomarkers (237)
- Animal (231)
- Tumor (219)
- Receptors (218)
- Mutation (215)
- Disease Models (205)
- Disease Models, Animal (203)
- Cell Line (197)
- Prospective Studies (195)
Articles 7861 - 7861 of 7861
Full-Text Articles in Entire DC Network
The Parenchymal Cells Of The Rat Pineal Gland, E Tapp, M Blumfield
The Parenchymal Cells Of The Rat Pineal Gland, E Tapp, M Blumfield
Faculty, Staff and Students Publications
Background: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare hematologic disorder with improved survival due to advancements in treatment. However, long-term cardiovascular morbidity and mortality remain significant. Established cardiovascular risk calculators, such as the 2008 Framingham Heart Study (FHS) global cardiovascular disease (CVD) and the American College of Cardiology/American Heart Association (ACC/AHA) atherosclerotic CVD (ASCVD) risk estimators, may not adequately account for the elevated and unique cardiovascular risks in iTTP survivors.
Objectives: To evaluate the discrimination and calibration of the ACC/AHA ASCVD and FHS global CVD models in predicting major adverse cardiovascular events (MACEs) among iTTP survivors.
Methods: This retrospective …